货号:A126336
同义名:
维生素A酸; 全反式维甲酸
/ Vitamin A acid; all-trans-Retinoic acid
All-Trans Retinoic Acid (Vitamin A acid)作为 RAR 核受体的激动剂,用于细胞疗法中的辅助试剂。All-Trans Retinoic Acid促进小鼠和人类多能干细胞分化为运动神经元,促进神经干细胞的神经元分化,促进人类胚胎干细胞 (ES 细胞) 分化为胰腺祖细胞,促进小鼠 ES 细胞的脂肪细胞分化,促进小鼠 ES 细胞的心室心肌细胞分化,促进粒细胞的终末分化。
HazMat Fee + There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.
| Type | HazMat fee for 500 gram (Estimated) |
| Excepted Quantity | USD 0.00 |
| Limited Quantity | USD 15-60 |
| Inaccessible (Haz class 6.1), Domestic | USD 80+ |
| Inaccessible (Haz class 6.1), International | USD 150+ |
| Accessible (Haz class 3, 4, 5 or 8), Domestic | USD 100+ |
| Accessible (Haz class 3, 4, 5 or 8), International | USD 200+ |


| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| 描述 | Retinoic acid receptors (RARs) are members of the super‐family of nuclear hormone receptors, which directly regulate the transcription of their target genes in the nucleus. Retinoic acid, the active metabolite of vitamin A, is a ligand for retinoic acid receptor (RAR) and retinoid X receptor (RXR). It has pleiotropic effects on growth, differentiation, proliferation, and development, and determines embryonic pattern formation and inhibits tumor growth. Addition of tretinoin significantly suppressed the remarkably elevated MMP-13 mRNA expression in the keloid‐derived dermal fibroblasts, with the peak suppression at 12h[3]. Tretinoin also prevented the cytotoxicity of H2O2 in cultured human mesangial cells by increasing both the catalase activity and the reduced glutathione content in dose- and time-dependent manner[4]. Retinoic acid at 10 μM inhibited the migration of Aspc-1 and Panc-1 cells indirectly through its inhibitory effects on cancer associated fibroblasts (CAFs) and inhibited epithelial-mesenchymal transition of tumor cells by decreasing IL-6 secretion of CAFs[5]. Neural stem cells (NSCs) treated with 1 µM retinoic acid for 4 days showed increased HRas and Tuj1 levels together with the increase in the active HRas level, which was required for NSC differentiation into neurons and murine brain development[6]. |
| Concentration | Treated Time | Description | References | |
| HepG2 | 5 µM and 10 µM | 48 hours | Enhanced the cytotoxicity of sorafenib | Cancer Sci. 2015 May;106(5):567-75 |
| Human fetal lung capillary endothelial precursor cells | 0.01, 0.1, 1 µM | 24 hours | To evaluate the effect of RA on endothelial cell proliferation, results showed RA increased cell proliferation in a concentration-dependent manner. | Am J Respir Cell Mol Biol. 2005 Dec;33(6):622-8. |
| THP-1 cells | 10 µM | 24 hours | To evaluate the inhibitory effect of Palovarotene on HSV-1 replication, results showed RA inhibited HSV-1 replication in a dose-dependent manner. | iScience. 2024 Jun 4;27(7):110144 |
| Hep3B | 5 µM and 10 µM | 48 hours | Enhanced the cytotoxicity of sorafenib | Cancer Sci. 2015 May;106(5):567-75 |
| HLF | 5 µM and 10 µM | 48 hours | Enhanced the cytotoxicity of sorafenib | Cancer Sci. 2015 May;106(5):567-75 |
| HLE | 5 µM and 10 µM | 48 hours | Enhanced the cytotoxicity of sorafenib | Cancer Sci. 2015 May;106(5):567-75 |
| HuH6 | 5 µM and 10 µM | 48 hours | Enhanced the cytotoxicity of sorafenib | Cancer Sci. 2015 May;106(5):567-75 |
| PLC/PRF/5 | 5 µM and 10 µM | 48 hours | Enhanced the cytotoxicity of sorafenib | Cancer Sci. 2015 May;106(5):567-75 |
| neurons | 2 μM | 1 week | to induce neuronal differentiation | Nat Biotechnol. 2011 Aug 10;29(9):824-8. |
| GABAergic neurons | 1 μM | 7 days | to induce GABAergic neuron differentiation | Nat Biotechnol. 2011 Aug 10;29(9):824-8. |
| mouse iPSCs | 10 M | Differentiation of mouse iPSCs into neurospheres | Bioeng Transl Med. 2022 Sep 10;8(5):e10406. | |
| femoral head chondrocytes | 10 μM | 3 days | To investigate the effect of retinoic acid on aggrecan degradation in chondrocytes, results showed reduced aggrecan degradation products in Ndst1+/− samples upon RA treatment. | Osteoarthritis Cartilage. 2020 Jul;28(7):977-987. |
| Neuro-2a (N2A) cells | 2 μM | 5 days | Induced differentiation of Hb9GFP mouse stem cells into motor neurons | Nat Commun. 2017 Jul 5;8:16063. |
| iPSC-derived motoneurons | 1 µM | 4-10 days | Used to induce differentiation of iPSCs into motoneurons, results showed that retinoic acid at 1 µM successfully induced motoneuron differentiation. | Nat Commun. 2015 Jan 12;6:5999. |
| Administration | Dosage | Frequency | Description | References | ||
| Balb/c mice | Pristane-induced lupus model | Oral | 1 mg/kg | Daily administration from 3 weeks to 3 months of age (tRA pre-treatment) or from 3 to 9 months of age (tRA post-treatment) | Investigate the role of tRA at different stages of lupus, finding that tRA pre-treatment exacerbates glomerulonephritis while post-treatment has immunosuppressive effects | Front Immunol. 2020 Mar 20;11:408 |
| Mouse | Embryonic stem cells | Culture medium | 5 µM | 7 days | Induced differentiation of embryonic stem cells | Sci Adv. 2021 Oct 29;7(44):eabk2775 |
| Mice | Osteoporosis model | Gavage | 70 mg/kg | Once daily for 2 weeks | Establish an osteoporosis model, results indicated the model was successfully established | Polymers (Basel). 2018 Feb 14;10(2):185 |
| Mice | Osteoporosis model | Gavage | 70 mg/kg | Once daily for 2 weeks | To induce an osteoporosis model in mice by administering retinoic acid, the results showed that serum calcium and ALP levels in the model group were significantly increased, indicating the successful establishment of the osteoporosis model. | Polymers (Basel). 2018 Feb 14;10(2):185 |
| ICR mice | UVB-induced skin damage model | Oral and topical application | 2 mg/kg | Once daily for one week | Retinoic acid as the positive control improved UVB-induced skin damage but did not significantly reduce oxidative stress and inflammation, and caused liver damage. | Int J Mol Sci. 2022 Sep 16;23(18):10833 |
| Dose | Mice: 1 mg/kg - 10 mg/kg[3] (i.p.) Rat: 10 mg/kg, 15 mg/kg[4] (p.o.), 1 mg/kg - 50 mg/kg[5] (p.o.) Swiss mice: LD50 = 31 mg/kg (i.p.); 1100 mg/kg (p.o.)[6] |
| Administration | i.p., p.o. |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
3.33mL 0.67mL 0.33mL |
16.64mL 3.33mL 1.66mL |
33.28mL 6.66mL 3.33mL |
|
| CAS号 | 302-79-4 |
| 分子式 | C20H28O2 |
| 分子量 | 300.44 |
| SMILES Code | CC1(C(=C(CCC1)C)C=CC(=CC=CC(=CC(O)=O)C)C)C |
| MDL No. | MFCD00001551 |
| 别名 | 维生素A酸; 全反式维甲酸 ;Vitamin A acid; all-trans-Retinoic acid; ATRA; Vitinoin |
| 运输 | 蓝冰 |
| 存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Keep in dark place, sealed in dry, store in freezer, under -20°C |
| 溶解方案 |
DMSO: 50 mg/mL(166.42 mM),配合低频超声,并水浴加热至45℃助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
沪公网安备 31011702889066号
沪ICP备2024050318号-1